Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008

rance, legal and professional fees

associated with being a public company.

Employee stock-based compensation expense recorded in the fourth

quarter of 2007 was $5.2 million. Of the total $5.2 million of

non-cash charges, $1.0 million was recorded in R&D expenses and

$4.2 million was recorded in G&A expenses. In the third quarter of

2007 and the fourth quarter of 2006, total stock-based compensation was

$5.2 million and $1.6 million, respectively. For the full year of

2007, total stock-based compensation was $19.5 million, up from

$6.1 million in the prior year. The increase in stock-based

compensation is primarily the result of the higher fair value of

options granted during 2007 compared to options granted in prior

periods.

-- Net loss for the fourth quarter of 2007 was $20.7 million. This

compares to a net loss of $21.9 million in the third quarter of 2007,

and $11.9 million in the fourth quarter of 2006. For the full year of

2007, net loss was $74.1 million, up from $63.5 million for the full

year of 2006.

-- Net loss per common share for the fourth quarter of 2007 was $0.78,

compared to $0.82 in the third quarter of 2007 and $0.54 in the fourth

quarter of 2006. For the full year of 2007, net loss per common share

was $2.81, compared to $3.97 in the full year of 2006.

-- Cash and marketable securities decreased by $16.2 million during the

fourth quarter. Changes included $20.7 million of net losses and

decreases in accrued R&D expenses and accounts payable of $2.5 million,

offset by $5.3 million in non-cash depreciation, amortization, and

stock-based compensation expenses, decreases in prepaid expenses of

$1.6 million and net decreases in other working capital of

$0.1 million.

-- Vanda's cash, cash equivalents, an
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vion Pharmaceuticals Holds Special Meeting of Stockholders
2. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
4. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
9. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... company that develops and commercializes proprietary technologies and ... that it has received approval from the TSX ... outstanding common share purchase warrants ("the Warrants") of ... the Company,s May 2013 private placement financing. ...
(Date:4/17/2015)... LC Sciences LLC, a leading ... that it is seeking beta testers for the ... based targeted sequencing technology. The system offers cost-effective, ... accurate detection of rare variants. It utilizes novel ... company will collaborate with beta testers to generate ...
(Date:4/16/2015)... 16, 2015 Cambridge Semantics ... driven by Semantic Web technology, and Informa ... and services for the academic and scientific, professional ... joint solution ‘Smart Data Lake for Clinical Trial ... the 2015 Bio-IT ‘Best of Show’ Award. ...
(Date:4/16/2015)... , April 16, 2015  Schulman Associates IRB, ... technology, has signed a long-term lease on Laboratory Drive ... North Carolina . The location will house review ... to provide high quality reviews and customer service to ... represented Schulman in the deal, while Capital ...
Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Schulman IRB to Open Office in Research Triangle Park, N.C. 2
... /PRNewswire-FirstCall/ - Dynamic Ventures Corp. (OTC:BB: DYNV), announced today ... with One Tree Development Inc. for rights to market ... residential construction nationally and internationally. One Tree maintains offices ... One Tree is a corporation formed for the purpose ...
... launch of IntriMed Technologies and the opening of ... were announced today by IntriPlex Technologies, a global ... components for the data storage and healthcare industries. ... innovation, IntriMed ( www.intrimed.com ) focuses exclusively on ...
... Norgen Biotek Corp, a privately held Canadian biotechnology ... technology for application in sample preparation for nucleic ... today announced the expansion of its basket of ... urine concentration, preservation and isolation kits. With the ...
Cached Biology Technology:Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build. 2Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build. 3IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers 2IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers 3Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens 2
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... presented at the EORTC-NCI-AACR [1] Symposium on "Molecular targets and cancer ... 00.01 hrs CET on Friday 29 October. The Symposium takes place ... on the online abstracts from the time that they go up ... all the abstracts had to be submitted by 15 June, and ...
... Institute of Food and Agriculture awarded $3.8 million to ... at Virginia Tech to lead a multistate effort to ... United States. According to Tony Wolf, professor of ... create, refine, and encourage industry adoption of grape and ...
... Toronto, Canada and New Delhi, India, October 27, 2010 ... private sector companies on two continents have come together ... development of novel classes of antimalarials. This bold ... a deadly disease in desperate need of new treatments. ...
Cached Biology News:Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29 2USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry 2International malaria research consortium tackles deadly disease 2International malaria research consortium tackles deadly disease 3
JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -...
... used to detect the appearance of AcNPV ... cells as early as 8-24 hours post-infection. ... Titer Kit, which allows determination of baculovirus ... The FastPlax Antibody can also be used ...
synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Goat polyclonal to SIAH Interacting Protein ( Abpromise for all tested applications)....
Biology Products: